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ACCUMULATION OF CD4DCD25D/HIGHCD127LOW/- REGULATORY T
CELLS IN OSTEOARTHRITIS JOINTS – ANALYSIS OF FREQUENCY AND
PHENOTYPE IN SYNOVIAL MEMBRANE, SYNOVIAL FLUID AND
PERIPHERAL BLOOD
B. Moradi y, P. Schnatzer y, S. Hagmann y, N. Rosshirt y, T. Gotterbarm y,
H-M. Lorenz z, T. Tretter z, F. Zeifang y. yUniv. Clinic of Heidelberg, Dept. of
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Purpose: Osteoarthritis (OA) is the most common joint disease and up
to date there are no therapies to halt disease initiation or progression. It
is becoming more evident that all other joint structures are affected in
OA and that the progressive pathological changes in the joint tissues
perpetuate disease progression. The synovial membrane (SM) functions
as an important site for this complex cell interaction and the molecular
interplay. There is an increasing body of evidence that synovitis in OA
may not just result from, but also play an active role in disease onset and
progression. This could lead to a disturbed immune regulation in OA
joints with the predominance of inﬂammatory cells on one hand and a
defective peripheral immune tolerance on the other.
Naturally occurring regulatory Tcells (Treg), have been shown to play an
essential role in establishing the balance between pro- and anti-
inﬂammatory mechanisms in the periphery and maintaining self-tol-
erance both in rodents and humans. Their ability to suppress T cell
responses and thereby regulate immune reactions ascribes them a key
role in the pathophysiology of inﬂammation and makes them an
interesting target for treatment. The presence of Tregs in OA joints and
their functional status has not been assessed yet.
In this study we aimed to investigate the presence of Tregs in OA
patients and tomap their distribution between periphery and the target
organ. Datawere put in relation to resting Tcells and activated effector T
cells. Further, we assessed functional differences between peripheral
and synovial Tregs.
Methods: Data on 44 OA patients were prospectively collected. The
presence and phenotype of CD4þCD25- naive (Tn), CD4þCD25þ
CD127þ activated effector (Teff) and CD4þCD25þ/highCD127low/-
Tregs were assessed in concurrent samples of synovial membrane,
synovial ﬂuid (SF) and peripheral blood (PB) by multicolor ﬂow
cytometry analysis. Further, we analyzed functional differences
between peripheral and synovial Tregs by surface markers repre-
sentative of activation (CD45RA, CD45R0, CD69, CD62L), memory and
regulation (CD152, CD154, CD223, CD274, CD279, GITR).
Results: The synovial membrane contained a signiﬁcantly higher con-
centration of inﬁltrating CD4þ T cells in comparison to SF. A signiﬁcant
change of CD4þ T cell subsets was shown in the joint samples when
compared to PB, displaying the same pattern for SF and SM.
CD4þCD25þ/highCD127low/- Tregs showed a signiﬁcant accumulation
into the synovial ﬂuid (14.9  4 % of CD4þ T cells) and membrane (12 
5) when compared to concurrent PB samples (8.4  4.2; p < 0.05). In SF
a signiﬁcant decrease of CD4þCD25- Tns (23  15) was found when
compared to PB (40  9.2; p < 0.05) without any signiﬁcant change in
CD4þCD25þCD127þ Teffs (PB: 39.3  8.5; SF 42  11; n.s.). In SM the
decrease of CD4þCD25- Tns was even more evident (14  11.5, p <
0.001). Here, the percentage of CD4þCD25þCD127þ Teffs (OA: 51 17)
was signiﬁcantly increased compared to concurrent PB samples (OA:
39.3  8.5; p < 0.05). Both, PB and SM Tregs displayed a memory
phenotype (CD45ROþRA-) but synovial Tregs were activated effector
memory cells (CD62L-CD69þ), while peripheral Tregs were resting
central memory cells (CD62LþCD69-). Further, PB and SM Tregs sig-
niﬁcantly differed in markers associated with Treg function (CD152,
CD154, CD274, CD279, GITR).
Conclusions: This is, to the authors’ best knowledge, the ﬁrst study to
show that Tregs are enriched in OA joints. One underlying hypothesis
about Treg enrichment into the affected joints of inﬂammatory diseases
is that Tregs are either attracted or generated due to on-going inﬂam-
mation. We further detected a signiﬁcant increase of Teffs in the SM.
This taken into account, the accumulated Treg presence in the joints
could be understood as an attempt of the immune system to control the
inﬂammatory responses. Further, we showed that synovial Treg show
signiﬁcant increase of activation markers and markers associated with
Treg function suggesting that synovial Tregs are active and contribute to
joint homeostasis. Increasing Treg mediated suppressive capacity in the
joints could provide a new therapeutic approach in OA treatment.817
A SPLICE VARIANT OF ADAMTS4 IS EXPRESSED AS A PROTEIN IN
HUMAN OSTEOARTHRITIS SYNOVIUM AND CLEAVES AGGRECAN AT
THE INTERGLOBULAR DOMAIN
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of BioSci.s, Cardiff, United Kingdom; zDept of Rheumatology, Cardiff Univ.,
Cardiff, United Kingdom
Purpose: Osteoarthritis (OA) is a multifaceted disease involving
pathological changes in the articular cartilage, subchondral bone, sur-
rounding soft tissues, and synovium. Inﬂammation and proliferation of
synovium occurs in both early and late stage OA, and the synovium
produces many proinﬂammatory cytokines and destructive enzymes.
OA synovium is known to produce the ADAMTS4 and ADAMTS5 met-
alloproteinases, key enzymes in the cleavage of aggrecan and degra-
dation of cartilage. Aggrecan degradation is a crucial early event in the
pathogenesis of OA, and studies have found evidence for the involve-
ment of either ADAMTS4 or ADAMTS5, or both these enzymes, in the
progression of OA.
We have previously described a mRNA variant of ADAMTS4
(ADAMTS4_v1) in human synovial cell co-cultures obtained from OA
patients. This RNA message has only been found in OA synovium, and
not in OA cartilage or other tissues. If translated, it would result in a
protein identical to ADAMTS4, except that the C-terminal spacer
domain would be completely different, without homologies to
ADAMTS4. Thus it would be predicted to retain enzyme speciﬁcity for
aggrecan degradation, although properties dependent on the ADAMTS4
spacer domain would be lost. The purpose of this study was to deter-
mine if ADAMTS4_v1 is translated into a protein, expressed in vivo, and
capable of acting as an aggrecanase and cleaving other matrix
proteoglycans.
Methods: Polyclonal antibodies were raised against synthetic peptides
representing unique amino acid sequences in the C-terminus of
ADAMTS4_v1 protein. After these antibodies had been characterised, an
immunohistochemical study of human OA synovium was performed. A
mammalian expression vector coding for FLAG-tagged human
ADAMTS4 was mutated to contain the different sequence of
ADAMTS4_v1 and the resultant plasmid was used to transfect HEK293
cells. ADAMTS4_v1 protein produced by these cells was puriﬁed via the
FLAG epitope, and the ability of this recombinant protein to cleave
aggreacan, biglycan and decorin was investigated.
Results: An antibody speciﬁc for ADAMTS4_v1 protein was found to
bind to the synovial membrane surface on cryosections of human OA
synovium. The staining was most prominent in the superﬁcial layer of
the synovial membrane. The ADAMTS4_v1 protein could be detected in
cell lysates from OA synovial samples. The recombinant ADAMTS4_v1
protein demonstrated enzyme activity towards the target substrate in a
commercial aggrecanase 1 enzyme-linked immunosorbent assay. It was
also found to cleave aggrecan at the pathologically important Glu373 Y
374Ala aggrecanase site, and to cleave biglycan but not decorin.
Conclusions: The splice variant of ADAMTS4 (ADAMTS4_v1) is
expressed as a protein in vivo in human OA synovium, functions as an
aggrecanase, and cleaves other proteoglycan substrates. This splice
variant may be an important contributor to the loss of aggrecan from
the superﬁcial zone of OA cartilage.
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THE GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) PROTEIN IS
INVOLVED IN CORTICOSTEROID-INDUCED LEPTIN PRODUCTION BY
HUMAN OSTEOARTHRITIS SYNOVIAL FIBROBLASTS IN VITRO
O. Malaise, B. Relic, E. Charlier, S. Neuville, D. de Seny, M. Malaise. GIGA
Res. – Univ. of Liege – CHU Liege, Liege, Belgium
Purpose: Osteoarthritis (OA) can be considered as a metabolic disorder
and adipokine leptin is involved in osteoarthritis pathogenesis: leptin
synovial levels are higher in patients with OA knee than in control
subjects and leptin synovial and serum levels are correlated to the
radiologic severity of OA knee. We have previously shown that synovial
ﬁbroblasts themselves were able to produce leptin in vitro, with a
strong induction under glucocorticoid prednisolone treatment. Gluco-
corticoids are powerful anti-inﬂammatory drugs and glucocorticoid-
induced leucine zipper (GILZ) mediates parts of its anti-inﬂammatory
effect. In collagen-induced arthritis and in rheumatoid arthritis synovial
ﬁbroblasts, GILZ shows an anti-inﬂammatory action. On the other hand,
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S450glucocorticoids have also serious long-term adverse events, as mellitus
diabetes and osteoporosis.
GILZ is involved in osteogenic differentiation and reduces adipogenic
differentiation of mesenchymal stem cells. Previously, we have shown
that genistein promoted adipogenesis, but inhibited leptin production.
In regards to theses observations, the aim of this study was to deter-
mine GILZ’s implication in corticosteroid-induced leptin secretion.
Methods: Human synovial ﬁbroblasts were isolated from OA patients
during knee surgery. Lentiviral vectors were generated by co-trans-
fecting Lenti-X 293T cells (Clonetech, Belgium) with a pSPAX2 plasmid
(Addgene, Plasmid #12260), a VSV-G encoding vector and a GILZ
(TSC22D3) shRNA plasmid (#TRCN0000013793 (shRNA1), #TRCN0000
364625 (shRNA2) or #TRCN0000369187 (shRNA3), Sigma-Aldrich,
USA) or with a non target sequence encoding plasmid (Sigma, Belgium,
SHC002). Cells were treated with prednisolone, aldosterone, Compound
A, mifepristone, eplerenone and spironolactone. ELISA measured leptin
production in culture supernatant. GR, GILZ and GAPDH were analyzed
in total cell extracts by Western Blot.
Results:1.Glucocorticoid (GR)andmineralocorticoid (MR) receptorswere
both expressed by OA synovial ﬁbroblasts. Glucocorticoid prednisolone
induced GILZ expression in OA synovial ﬁbroblasts. Mineralocorticoid
aldosterone also inducedGILZexpression, but in a lowerextend. BothGILZ
expressionswere dependent onGR. Indeed, GR antagonist (mifepristone),
but not MR antagonists (eplerenone and spironolactone), inhibited pre-
dnisolone- and aldosterone-induced GILZ expressions. Previously, we
observed similar modulation for leptin secretion, with a stimulation by
prednisolone and aldosterone, through GR but not MR.
2. GILZ expression was already observed by western-blot after 24 h-
stimulation with prednisolone. Under prednisolone stimulation, leptin
secretion gradually increased day after day, with a similar proﬁle of
expression than GILZ, hypothesizing a link between GILZ and leptin
expression. Opposite to prednisolone, Compound A, a dissociative glu-
cocorticoid receptor agonist, did not induce neither leptin nor GILZ
expression in human OA SF. Theses observations suggested a link
between GILZ and leptin expression.
3. Upon prednisolone stimulation, GILZ-shRNA reduced GILZ expression
with 3 different shRNA. When GILZ was down regulated, prednisolone-
induced leptin was signiﬁcantly decreased compared to the controls.
Decrease of leptin expression was correlated to the degree of GILZ
extinction. GR down-regulationwas not affected by GILZ-silencing after
seven days of stimulation.
Conclusions: Leptin and GILZ’s modulations shared similar properties.
GILZ silencing led to a signiﬁcantly decrease expression of leptin under
prednisolone stimulation. These results suggest that GILZ could be
involved in prednisolone-induced leptin in OA synovial ﬁbroblasts.
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PIGMENTED VILLONODULAR SYNOVITIS (PVNS)- LIKE CHANGES IN
PERIPROTHETIC INTERFACE MEMBRANES
S. Soeder, A. Hartmann, A. Agaimy. Univ. of Erlangen and Nuernberg,
Erlangen, Germany
Purpose: PVNS is a tumour-like mesenchymal lesion of uncertain his-
togenesis that may occur at both intra-articular and extra-articular
sites. There have been infrequent reports about PVNS or similar changes
after total endoprothesis (TEP). In this study, we describe and quantify
the occurrence of PVNS-like lesions in the neosynovia following total
endoprothesis.
Methods: Periprothetic membrane specimens from 477 patients
undergoing replacement of their knee TEP were parafﬁn embedded,
sectioned andhematoxylin-eosin stained. For evaluation of irondeposits
the classic Prussian blue reactionwas used.Wear particleswere detected
byconventional and polarisationmicroscopy. In order to compare PVNS-
like lesions with genuine PVNS, 10 cases of the collective of PVNS-like
periprothetic membranes as well as 10 representative PVNS cases were
stained with antibodies against CD3, CD4, CD8, CD20, CD34, CD68,
CD138, mast cell tryptase (MCT), collagen IV and Mib-1/Ki67.
Results: The neosynovia displayed a broad spectrum of histological
changes. In 5,0 % (24 of 477) of all periprothetic membranes we found
histological lesions showing some features of PVNS. In 3,8 % (18 of 477) of
the cases the histology closely resembled PVNS with marked villous
hyperplasia, ﬁbrosis, iron deposits and a mixed cellular inﬁltrate com-
posed of mononuclear cells, ﬁbroblasts, foam histiocytes and multi-
nucleated giant cells with varying hemosiderin deposits. Wear particles
were detected in 63,3 % (302 of 477) of all perprotheticmembranes and in100% of the cases with features of PVNS (p-value <0,002). Regarding the
age of the patients, no statistically signiﬁcant difference was found
between neosynoviawith andwithout features of PVNS (69,4þ/-11,3 and
67,5þ/-11,3 respectively). Theelapsed timebetweenprimaryarthroplasty
and revision surgerywas 9,9þ/-6,4 years, a typical value for periprothetic
membranes of the wear type. Immunohistochemistryshowed a similar
pattern for PVNS and PVNS-like lesions, with a lower positivity for B- and
T-Cells and especially for cytotoxic T-cells in PVNS-like lesions.
Conclusions: PVNS- like lesions found in the neosynovia of peri-
prothetic membranes represent an exuberant ﬁbrohistiocytic reaction
and are likely induced by wear particles. Their development might be
governed by the same pathological principle responsible for the clas-
sical PVNS in synovial membranes, probably involving chronic inﬂam-
matory/ irritation-induced synovial hyperplasia. These ﬁndings might
provide an additional clue for the understanding of the pathological
mechanism of classical PVNS.820
SYNOVIAL TISSUE EXHIBITS MOLECULAR HETEROGENEITY IN
RESPONSE TO INTRAARTICULAR KNEE JOINT SURGERY
K.I. Barton, B.J. Heard, N.M. Solbak, M. Chung, Y. Achari, N.G. Shrive,
D.A. Hart, C.B. Frank. Univ. of Calgary, Calgary, AB, Canada
Purpose: Severe injury to the knee joint, such as anterior cruciate lig-
ament (ACL) tears and/or menisci damage often results in accelerated
osteoarthritis (OA). It is thought that there may be an injury-induced,
mechanical abnormality of the injured joint and subsequent interplay
between altered mechanics and biological changes, such as inﬂamma-
tion, which may lead to OA. In recent years, the role of synovium in the
pathophysiology of OA has gained importance. Clinical evidence sug-
gests that inﬂamed synovium can add to adjacent articular cartilage
damage, potentially contributing to OA. Histological analysis of synovial
tissue biopsies from OA patients has demonstrated abnormalities:
thickening, increased vascularity, and inﬂammatory inﬁltration. We
have previously demonstrated that normal synovial tissue is a homo-
genous tissue for biomarkers of inﬂammation. However, following ACL
reconstruction (ACL-R), the synovium exhibits increased mRNA levels
for select inﬂammatory markers. Currently, it is unknown whether
inﬂammation in the synovium tissue is uniformly distributed. Micro-
scopic observation of synovium for pathological changes may provide
relevant prognostic information, which can help in the early identi-
ﬁcation of the disease and possibly inﬂuence the therapeutic decisions.
The hypothesis was that synovial tissue from different locations of the
knee joint would demonstrate a uniform pattern in inﬂammatory
marker expression.
Methods: Six skeletally mature, female Suffolk Cross sheep were
allocated into three groups: ACL-R (n ¼ 2), surgical sham (n ¼ 2), and
non-operated controls (n ¼ 2). Surgeries involved an arthrotomy to the
right stiﬂe joint. For the ACL-R, the stiﬂe joint was opened on the
lateral side and the patella was dislocated medially to expose the ACL.
A dry pneumatic drill was ﬁtted over the guide pin and used to core
out the uninjured ACL on its femoral insertion. The bone core was then
released and immediately ﬁxed in place using two crossed Kirschner
wires. For the surgical sham, a similar arthrotomy and surgical
approach to the ACL-R was used. The stiﬂe joint was opened on the
lateral side and the patella was dislocated medially to expose the ACL,
followed by a similar standard closure. There was no injury to the
ligaments in sham animals. The control group did not have the inter-
vention. Animals were sacriﬁced 2 weeks after surgery and synovium
tissue was collected from four different locations (Fig. 1), and snap
frozen for mRNA analysis using real time qPCR. Part of the synovium
was ﬁxed for histological analysis and evaluated for microscopic
changes with Hematoxylin and Eosin staining. ANOVA with Bonferroni
post-hoc analysis was used to determine differences in mRNA
expression between groups, using SPSS 19.0.
Results: Analysis of the synovium tissue exhibited that pro-inﬂamma-
tory interleukins (IL) were generally elevated in the operated animals
but not in the shams or non-operated controls. IL-8 and IL-1b were
found to be distinctly higher in the lateral region of the synovium
(Fig. 2A-B). Furthermore, matrix metalloproteinase (MMP)-13 was
found to be higher in the lateral region (Fig. 2C). In contrast, IL-6 mRNA
expression levels in the four locations of the synovium was similar
(Fig. 2D). The surgical sham animals did not exhibit the same response
as the ACL-R animals. Histological observations of the four locations of
